Immunethep
PrivateLast Round
Grant
Apr 2, 2025
Total Funding Raised
$6.49M
Company Overview
Immunethep is a biotechnology company that develops preventive and therapeutic anti-bacterial immunotherapies targeting a shared virulence mechanism in pathogenic bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunethep Comparables
Compare Immunethep with similar companies based on industry and business-model similarity.
Immunethep Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 2, 2025 | ||||
| Grant | Feb 25, 2025 | ||||
| Early Funding | Jul 31, 2024 | ||||
| Grant | Oct 18, 2022 | ||||
| Grant | Oct 23, 2017 | ||||
Seed | Apr 13, 2015 |
Key People
Founding team and executive leadership
Immunethep Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Beta Capital | Early Funding |
| Portugal Ventures | Seed |
| IM Gestão de Ativos | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2025
Monthly visitors grew 89% MoM, reaching 603.
- May 2, 2025
Monthly visitors increased 250% MoM.
Immunethep Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immunethep's valuation, stock price, and market status.